Ardelyx, Inc. provided earnings guidance for full year 2023. For the year, the company expected net IBSRELA sales revenue for full year 2023 to be between $72 million and $77 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.79 USD | -0.76% | -3.35% | +25.65% |
May. 09 | Ardelyx Insider Sold Shares Worth $2,522,217, According to a Recent SEC Filing | MT |
May. 09 | Ardelyx Insider Sold Shares Worth $1,831,503, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.65% | 1.82B | |
+8.29% | 114B | |
+10.21% | 104B | |
-11.90% | 22.41B | |
+0.47% | 22.28B | |
-5.57% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- ARDX Stock
- News Ardelyx, Inc.
- Ardelyx, Inc. Provides Earnings Guidance for Full Year 2023